Trial NCT04473053; ISRCTN14212905; EudraCT 2020-002230-3
Publication Quinn TM, medRxiv (2021) (preprint)
Dates: 2020-09-01 to 2021-02-28
Funding: Mixed (LifeArc and Oxford University COVID-19 Research Response Fund. Nichi-Iko (Japan) supplied Futhan (intravenous Nafamostat) for the trial.)
Conflict of interest: No